Vanguard Personalized Indexing Management, LLC Athira Pharma, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.61 Billion
- Q1 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 14,165 shares of ATHA stock, worth $4,391. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,165
Previous 38,983
63.66%
Holding current value
$4,391
Previous $22,000
86.36%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ATHA
# of Institutions
61Shares Held
18.4MCall Options Held
14.3KPut Options Held
4.4K-
Perceptive Advisors LLC New York, NY5.4MShares$1.67 Million0.06% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.2MShares$992,2060.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.54MShares$476,7530.0% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$462,7650.49% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$462,7650.02% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $11.7M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...